Spine Biologics Market - Forecast(2021 - 2026)

Report Code: HCR 0568 Report Format: PDF + Excel (Delivery in 48 Hrs)

Spine Biologics Market Overview

The Spine Biologics Market size is estimated to reach $3.7 Billion by 2025, growing at a CAGR of 4.7% during the forecast period 2020-2025. Spine biologics consists of biomaterials that can be used in the treatment of degenerative disc diseases, spinal cord injuries, and bone fusion surgeries. However, Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through inflammatory stage, repair stage, and remodeling stage. Rising incidence of spinal disorders and awareness on the newly developed spine treatment techniques and devices are driving the growth of Spinal Biologics Market during the forecast period 2020-2025.

Spine Biologics Market Report Coverage

The report: “Spine Biologics Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Spine Biologics Market. 
By Product Type: Spinal Allografts, Machined Bones Allograft, Demineralized Bone Matrix, Bone Graft Substitutes, Bone Morphogenetic Proteins, Synthetic Bone Grafts, and Cell based Matrix.
By Surgery Type: Open Spine Surgery, Minimally Invasive Spine Surgery, Anterior Cervical Discectomy and Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Anterior Lumbar Interbody Fusion (ALIF), Lumbar Interbody Fusion (LLIF), and Others.
By Geography: North America, Asia-Pacific, Europe, and Rest of the world.

Key Takeaways

  • Geographically, North America held a significant market share in the global Spine Biologics Market during the period of 2019. Owing to the presence of the elderly population, increasing adoption of minimally invasive procedure, and rising prevalence of spine disorders.
  • Factors such as Spinal allografts dominated the overall market in 2019 owing to the numerous benefits associated with its usage and the Adoption of allografts over autografts is swiftly increasing properties such as immediate structural support and osteoconductivity.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Spine Biologics Market report.

Spine Biologics Market Segment Analysis - By Product Type

Based on Product Type, Spine Biologics Market is segmented into Spinal Allografts, Machined Bones Allograft, Demineralized Bone Matrix, Bone Graft Substitutes, Bone Morphogenetic Proteins, Synthetic Bone Grafts, and Cell based Matrix. Spinal allografts hold the major share in the market during the forecast period 2019. This Owing to the numerous benefits associated with its usage and Adoption of allografts over autografts is swiftly increasing properties such as immediate structural support and conductivity. Bone Graft Substitutes segment is also set to be the fastest growing CAGR of 5.6% during the forecast period 2020-2025. This is owing to high adoption by surgeons and an increasing number of spinal fusion procedures.

Spine Biologics Market Segment Analysis - By Surgery

Based on Surgery Type, Spine Biologics Market is segmented into Open Spine Surgery, Minimally Invasive Spine Surgery, Anterior Cervical Discectomy, and Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), and others. Minimally invasive spine (MIS) surgery held the major share in 2019. This is owing to surgical approach or technique intended to provide equivalent or superior outcomes compared with conventional open spine surgery owing to limiting approach related surgical morbidity. Anterior Cervical Discectomy is also set to be the fastest growing with a CAGR during the forecast period 2020-2025.this is owing to the reductions in patient morbidity, length of hospital stays, and costs.

Spine Biologics Market Segment Analysis - By Geography

Based on Geography the Spine Biologics Market is segmented into North America, Europe, Asia-Pacific, Rest of World. North America had the largest share in terms of revenue with an overall share of 38.9% in 2019. This is owing to the increased adoption of minimally invasive surgeries, and the rising prevalence of spine disorders such as spinal stenosis, disc-related issues, and spondylolisthesis. Asia Pacific is also set to be the fastest growing market during the forecast period 2020-2025. This is owing to the medical and health awareness of people in the region which is driving the growth of Asia Pacific during the forecast period 2020-2025.

Spine Biologics Market Drivers

Spine Related Health Issues:

Growing cases of spine related health issues are one of the major driving forces for the Spine Biologics market. People affecting with spinal disorders are significantly growing all over the world. The above 65-year-old peoples are undergoing spinal problems and fusion surgeries the treatment which is providing a significant boost to the Spine Biologics market Growth. 

Spine Biologics Market Challenges

In Spine Surgery biologics the research and development is challenged by the cost of bringing new product to market and the associated reimbursements of the products once it reaches the market. By this, the cost is increasing and the reimbursements decreasing, investors are significantly less likely to risk developing a new product. And are few challenges restraining the growth during the forecast period 2020-2025. 

Spine Biologics Market Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Spine Biologics Market. Key companies of this market are Zimmer Biomet Holdings inc, Nuvasive Inc, Depuy Synthes, Orthofix International N.V, K2M, Inc, Exactech, Inc, DR PRP USA LLC, Arthrex, Inc. Nutech, Wright Medical Technology, Inc.and others.

Developments:

  • In September 2017, NuVasive Announces Acquisition Of Vertera Spine. he acquisition of Vertera Spine reflects NuVasive's continued commitment to pursue strategic opportunities as it builds out its advanced materials science portfolio to complement the Company's position as the innovation leader in spine.
  • In May 2016, NuVasive has Launches Next Generation Biologics Technology. NuVasive, Inc is a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, has announced the U.S. launch of the newest solution in its biologics portfolio, AttraX Putty.

1. Spine Biologics Market Overview
    1.1 Definitions and Scope
2. Spine Biologics Market Executive Summary
    2.1 Market revenue, Market Size and Key Trends
    2.2 Key trends by Product Type
    2.3 Key trends by Surgery Type
    2.4 Key trends by Geography
3. Spine Biologics Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Spine Biologics Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Spine Biologics Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Spine Biologics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Spine Biologics Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Spine Biologics Market – By Product Type(Market Size -$Million/$Billion)
    8.1 Spinal Allografts
        8.1.1 Machined Bones Allograft
        8.1.2 Demineralized Bone Matrix
    8.2 Bone Graft Substitutes
        8.2.1 Bone Morphogenetic Proteins
        8.2.2 Synthetic Bone Grafts
    8.3 Cell based Matrix
9. Spine Biologics Market – By Surgery (Market Size -$Million/$Billion)
    9.1 Open Spine Surgery
    9.2 Minimally Invasive Spine Surgery
    9.3 Anterior Cervical Discectomy and Fusion (ACDF)
    9.4 Posterior Lumbar Interbody Fusion (PLIF)
    9.5 Anterior Lumbar Interbody Fusion (ALIF)
    9.6 Lateral Lumbar Interbody Fusion (LLIF)
    9.7 Others
10. Spine Biologics Market - By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia 
        10.3.6 Rest of Asia-Pacific
    10.4 Rest of World
        10.4.1 Africa
        10.4.2 Middle East
        10.4.3 South America
11. Spine Biologics Market Entropy
12. Spine Biologics Market - Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Spine Biologics Market - Key Company List by Country Premium Premium
14. Spine Biologics Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Zimmer Biomet Holdings inc
    14.3 Nuvasive, Inc.
    14.4 Depuy Synthes
    14.5 Orthofix International N.V.
    14.6 K2M, Inc
    14.7 Exactech, Inc.
    14.8 DR PRP USA LLC
    14.9 Arthrex, Inc.
    14.10 Nutech
    14.11 Wright Medical Technology, Inc.
"*Financials for private companies would be provided on a best efforts basis”.